Affiliation:
1. G
2. Government Dental College and Hospital, Aurangabad, Maharashtra, India
Abstract
Corona virus disease was declared as pandemic in 2020. The second wave of covid 19 in India was completely influenced by the fatal complication of covid 19 called Mucormycosis. It was declared as an epidemic in India after 2 wave. The use of Corticosteroids in the management of covid 19 and uncontrolled diabetes mellitus with other systemic illness has shown tremendous immunosuppression which has ultimately caused Mucormycosis. Mucormycosis is rare in mandible. We are presenting a case report with brief discussion of 9 patients having post covid Mucormycosis along with osteomyelitis of the mandible, the rarest form of the post covid infection, which was managed surgically as well as with adjuvant antibacterial and antifungal drugs followed by post-operative prosthetic rehabilitation. This fatal infection has to be kept in mind in covid 19 active cases as well as in recovered patients, especially in those having comorbidities and judicious use of cortico-steroids should be recommended.
Publisher
IP Innovative Publication Pvt Ltd
Reference15 articles.
1. Sharma S, Grover M, Bhargava S, Samdani S, Kataria T, Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.J Laryngol Otol 2021;135(5):442-7
2. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections
3. COVID-19-associated mucormycosis: Case report and systematic review
4. Paultauf A, Virchow’s archive for pathological anatomy and physiology and for clinical medicine.Virchows Archiv 1885;102:543-64
5. Arastehfar A, Carvalho A, DeVeerdonk FLV, Jenks JD, Koehler P, Krause R, COVID-19 associated pulmonary aspergillosis (CAPA)-from immunology to treatment.J Fungi 2020;6(2):91